| Breakdown | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 135.59B | 136.15B | 124.97B | 113.63B | 92.46B |
| Gross Profit | 19.73B | 20.51B | 18.07B | 16.55B | 13.35B |
| EBITDA | 9.65B | 10.96B | 8.95B | 7.98B | 5.26B |
| Net Income | 6.72B | 7.58B | 5.92B | 5.32B | 3.58B |
Balance Sheet | |||||
| Total Assets | 111.00B | 112.46B | 101.37B | 95.38B | 83.99B |
| Cash, Cash Equivalents and Short-Term Investments | 34.97B | 30.53B | 28.54B | 27.19B | 26.34B |
| Total Debt | 686.00M | 599.00M | 927.00M | 985.00M | 141.00M |
| Total Liabilities | 52.08B | 56.85B | 50.65B | 48.98B | 41.10B |
| Stockholders Equity | 58.50B | 55.23B | 50.39B | 46.16B | 42.73B |
Cash Flow | |||||
| Free Cash Flow | 8.22B | 6.36B | 3.88B | 5.92B | 9.03B |
| Operating Cash Flow | 9.44B | 8.24B | 6.94B | 6.33B | 9.40B |
| Investing Cash Flow | -3.86B | -2.54B | -3.12B | -3.73B | 63.00M |
| Financing Cash Flow | -3.75B | -3.88B | -2.40B | -2.09B | -1.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥193.60B | 4.98 | 17.09% | 2.94% | 9.67% | 45.58% | |
76 Outperform | ¥22.89B | 10.49 | ― | 3.83% | 41.87% | 167.99% | |
75 Outperform | ¥99.55B | 14.91 | ― | 2.72% | -0.41% | -10.32% | |
74 Outperform | ¥51.29B | 13.51 | ― | 4.12% | -4.88% | -26.05% | |
65 Neutral | ¥30.39B | -17.27 | ― | 5.16% | 1.71% | -29.37% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥36.36B | 40.99 | 1.55% | 1.34% | -34.13% | -31.24% |